BackVistagen Therapeutics Overview

Vistagen Therapeutics Long Term Debt

Vistagen Therapeutics's long-term debt is $250K.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$249000.00
↓ 73.73% YoYΔ $-699000.00 vs prior year quarter

Peer average

Loading

Vistagen Therapeutics Long Term Debt History

Loading

Vistagen Therapeutics vs. peers: Long Term Debt Comparison

Loading

Vistagen Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vistagen Therapeutics (VTGN) FAQ

As of the most recent data (March 2026), VTGN shows a long-term debt of $250K. That compares with $950K in the prior-year period — down 73.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VTGN's long-term debt is now $250K (was $950K) — a 73.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vistagen Therapeutics is outperforming or lagging.

Tracking VTGN's long-term debt over time shows whether Vistagen Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $250K That compares with $950K in the prior-year period — down 73.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Vistagen Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $250K) with ownership activity and broader fundamentals.

Vistagen Therapeutics's long-term debt is $250K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.